Collaborations

BT Partnership

  • ONCOSEC

    - OncoSec Medical Incorporated is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies with new technologies to stimulate the body’s immune system to target and attack cancer.
    - OncoSec Medical Incorporated’s investigational platform, Intratumoral IL-12, is designed to enhance local delivery and uptake of DNA-based therapeutics directly into tumors.